The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Saks Samuel R since 2007.
The trader's CIK number is 1365615.
At the time of the last reporting, Saks Samuel R was the Chief Executive Offi of Tonix Pharmaceuticals Holding Corp.. (stock ticker symbol TNXP).
Also see all insider trading activities at Tonix Pharmaceuticals Holding Corp..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | ASPX | 2,175 | $26,100 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | JAZZ | 28,638 | $383,839 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | TNXP | 0 | $0 | 0 | $0 | 2,100 | $0 |
2016 | TNXP | 75,000 | $150,000 | 0 | $0 | 0 | $0 |
2015 | TNXP | 10,000 | $75,000 | 0 | $0 | 0 | $0 |
2013 | TNXP | 5,883 | $0 | 0 | $0 | 0 | $0 |
1. Auspex Pharmaceuticals, Inc. (ASPX)
2. Jazz Pharmaceuticals Plc (JAZZ)
3. Tonix Pharmaceuticals Holding Corp. (TNXP)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-02-10 | ASPX | Buy | 2,175 | 12.00 | 26,100 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-11-14 | JAZZ | Buy | 4,900 | 13.39 | 65,611 |
2007-11-12 | JAZZ | Buy | 10,438 | 13.37 | 139,503 |
2007-11-13 | JAZZ | Buy | 13,300 | 13.44 | 178,725 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-05-27 | TNXP | Option Ex | 750 | .00 | 0 |
2016-02-25 | TNXP | Option Ex | 600 | .00 | 0 |
2017-02-09 | TNXP | Option Ex | 750 | .00 | 0 |
2016-06-21 | TNXP | Buy | 25,000 | 2.00 | 50,000 |
2016-06-21 | TNXP | Buy | 25,000 | 2.00 | 50,000 |
2016-06-21 | TNXP | Buy | 25,000 | 2.00 | 50,000 |
2015-07-17 | TNXP | Buy | 10,000 | 7.50 | 75,000 |
2013-08-14 | TNXP | Buy | 5,883 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saks Samuel R (Chief Executive Offi of Tonix Pharmaceuticals Holding Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.